Abstract:Purpose This paper presents the effect of Mst1-Nrf2 on myocardial injury in type 2 diabetic mice through autophagy. Method C57BL/6N wild-type mice, Mst1 knockout mice and Mst1 knockout mice interfered by Keap1-Nrf2 pathway inhibitors are divided into wild group, Mst1 group, Mst1-Nrf2 group, diabetic cardiomyopathy group (DCM), DCM+Mst1 group and DCM+ Mst1-Nrf2 group. Each group contains 5 mice. Mice in DCM group, DCM+Mst1 group and DCM+Mst1-Nrf2 group are given high-glucose and high-fat diet for 4 weeks, then intraperitoneally injected 40mg/kg streptozotocin(STZ). Meanwhile, high-glucose and high-fat diet is continued for 8 weeks. Body weight and fasting blood glucose are measured every week. Mice in Mst1-Nrf2 group and mice in DCM+Mst1-Nrf2 group are given interference of Keap1-Nrf2 pathway inhibitors, and intraperitoneally injected for 4 weeks at a dose of 5mmol/L. Results After 8 weeks of STZ injection, the body weight of mice in DCM+Mst1 group and mice in DCM+ Mst1-Nrf2 group increases and fasting blood glucose level decreases, the differences are statistically significant (P<0.01). Compared with the wild group, the fasting glucose level of mice in Mst1 group and Mst1-Nrf2 group decreases after 8 weeks (P<0.01). Compared with the wild group, the degree of myocardial fibrosis in Mst1 group and Mst1-Nrf2 group is significantly reduced, while the level of myocardial fibrosis in DCM group is significantly increased (P < 0.01). After 8 weeks of STZ injection, the degree of myocardial fibrosis in DCM+Mst1 group and DCM+ Mst1-Nrf2 group is significantly reduced. Compared with the wild group, the expression of myocardial Beclin1 protein in Mst1 group and Mst1-Nrf2 group is significantly increased (P < 0.01); Compared with DCM group, myocardial Beclin1 protein expression is significantly increased in DCM+Mst1 group and DCM+Mst1-Nrf2 group(P< 0.01). Compared with the wild group, the expression of p62 protein in myocardium of Mst1 group and Mst1-Nrf2 group is significantly decreased (P < 0.01). Compared with DCM group, the expression of p62 protein in myocardium of DCM+Mst1 group and DCM+Mst1-Nrf2 group is decreased significantly (P< 0.01). Compared with the wild group, myocardial Nrf2 protein expression in Mst1 group and Mst1-Nrf2 group is significantly increased (P < 0.01). Compared with DCM group, myocardial Nrf2 protein expression of mice in DCM+Mst1 group and DCM+ Mst1-Nrf2 group is significantly increased (P < 0.01). Conclusion Mst1-Nrf2 promotes autophagy in type 2 diabetic mice and inhibits the progression of diabetic cardiomyopathy.

Mst1-Nrf2 regulates myocardial injury in type 2 diabetic mice through autophagy

Expression Changes Of Mitogen-Actilvated Protelin Kinase Phosphatase-1 (Mkp-1) In Myocardium Of Streptozotocin-Induced Diabetic Rats

MST1 Coordinately Regulates Autophagy and Apoptosis in Diabetic Cardiomyopathy in Mice

Mst1 Knockdown Alleviates Cardiac Lipotoxicity and Inhibits the Development of Diabetic Cardiomyopathy in Db/db Mice.

Mst1 Inhibits CMECs Autophagy and Participates in the Development of Diabetic Coronary Microvascular Dysfunction

Macrophage Migration Inhibitory Factor Deficiency Augments Cardiac Dysfunction in Type 1 Diabetic Murine Cardiomyocytes

Exercise training suppresses Mst1 activation and attenuates myocardial dysfunction in mice with type 1 diabetes

Relationship Between Mechanism of SIRT1-mediated Mitophagy in Myocardium and Mfn2 in Diabetic Rats

Mst1 Knockout Alleviates Mitochondrial Fission and Mitigates Left Ventricular Remodeling in the Development of Diabetic Cardiomyopathy

Inhibition of myocyte-specific enhancer factor 2A improved diabetic cardiac fibrosis partially by regulating endothelial-to-mesenchymal transition

Nrf2 prevents diabetic cardiomyopathy via antioxidant effect and normalization of glucose and lipid metabolism in the heart

Activation of AMPK/p38/Nrf2 is involved in resveratrol alleviating myocardial ischemia-reperfusion injury in diabetic rats as an endogenous antioxidant stress feedback

Abstract 279: Stromal Cell-derived Factor-1 Prevents from Diabetic Cardiomyopathy Via Cxcr7/ampk-mediated Nrf2 Activation in Type 2 Diabetic Mice

TRPM2 knockdown attenuates myocardial apoptosis and promotes autophagy in HFD/STZ-induced diabetic mice via regulating the MEK/ERK and mTORC1 signaling pathway

Inhibition of MST1 Ameliorates Neuronal Apoptosis Via GSK3 I3 / I3-TrCP/ NRF2 Pathway in Spinal Cord Injury Accompanied by Diabetes

Protective effect of SIRT 1 agonist on myocardium in diabetic mice

NADPH Oxidase Mediates Oxidative Stress and Ventricular Remodeling through SIRT3/FOXO3a pathway in Diabetic Mice

Exercise Alleviates Cardiac Remodelling in Diabetic Cardiomyopathy Via the Mir-486A-5p-mst1 Pathway.

Inhibition of MST1 Ameliorates Neuronal Apoptosis Via GSK3β/β-TrCP/NRF2 Pathway in Spinal Cord Injury Accompanied by Diabetes

Nrf2 prevents diabetic cardiomyopathy via antioxidation and normalization of glucose and lipid metabolism in the heart

Overexpression of MD1 ameliorates pathological myocardial remodeling in diabetic cardiomyopathy by TLR4/STAT3 signaling pathway